| Visible-light-triggered prodrug nanoparticles combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy J Choi, MK Shim, S Yang, HS Hwang, H Cho, J Kim, WS Yun, Y Moon, ... ACS nano 15 (7), 12086-12098, 2021 | 124 | 2021 |
| Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy MK Shim, Y Moon, S Yang, J Kim, H Cho, S Lim, HY Yoon, JK Seong, ... Biomaterials 261, 120347, 2020 | 86 | 2020 |
| Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death Y Moon, MK Shim, J Choi, S Yang, J Kim, WS Yun, H Cho, JY Park, Y Kim, ... Theranostics 12 (5), 1999, 2022 | 79 | 2022 |
| Emerging albumin-binding anticancer drugs for tumor-targeted drug delivery: current understandings and clinical translation H Cho, SI Jeon, CH Ahn, MK Shim, K Kim Pharmaceutics 14 (4), 728, 2022 | 67 | 2022 |
| All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy S Song, MK Shim, S Yang, J Lee, WS Yun, H Cho, Y Moon, JY Min, ... Bioactive Materials 28, 358-375, 2023 | 41 | 2023 |
| Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity S Yang, MK Shim, S Song, H Cho, J Choi, SI Jeon, WJ Kim, W Um, ... Biomaterials 290, 121841, 2022 | 36 | 2022 |
| Perspectives for improving the tumor targeting of nanomedicine via the EPR effect in clinical tumors J Kim, H Cho, DK Lim, MK Joo, K Kim International journal of molecular sciences 24 (12), 10082, 2023 | 30 | 2023 |
| Sustained and long-term release of doxorubicin from PLGA nanoparticles for eliciting anti-tumor immune responses J Kim, Y Choi, S Yang, J Lee, J Choi, Y Moon, J Kim, N Shim, H Cho, ... Pharmaceutics 14 (3), 474, 2022 | 28 | 2022 |
| A comparative study on albumin-binding molecules for targeted tumor delivery through covalent and noncovalent approach W Um, J Park, A Youn, H Cho, S Lim, JW Lee, HY Yoon, DK Lim, JH Park, ... Bioconjugate chemistry 30 (12), 3107-3118, 2019 | 24 | 2019 |
| Cathepsin B-overexpressed tumor cell activatable albumin-binding doxorubicin prodrug for cancer-targeted therapy H Cho, MK Shim, S Yang, S Song, Y Moon, J Kim, Y Byun, CH Ahn, K Kim Pharmaceutics 14 (1), 83, 2021 | 17 | 2021 |
| In situ albumin-binding and esterase-specifically cleaved BRD4-degrading PROTAC for targeted cancer therapy H Cho, SI Jeon, MK Shim, CH Ahn, K Kim Biomaterials 295, 122038, 2023 | 16 | 2023 |
| Tumor-specific monomethyl auristatin E (MMAE) prodrug nanoparticles for safe and effective chemotherapy H Cho, MK Shim, Y Moon, S Song, J Kim, J Choi, J Kim, Y Lee, JY Park, ... Pharmaceutics 14 (10), 2131, 2022 | 11 | 2022 |
| Fluorescence-Based Mono-and Multimodal Imaging for In Vivo Tracking of Mesenchymal Stem Cells WS Yun, H Cho, SI Jeon, DK Lim, K Kim Biomolecules 13 (12), 1787, 2023 | 9 | 2023 |
| Recent developments in chemodrug-loaded nanomedicines and their application in combination cancer immunotherapy N Shim, H Cho, SI Jeon, K Kim Journal of Pharmaceutical Investigation 54 (1), 13-36, 2024 | 6 | 2024 |
| Multi-functional nanomedicines for combinational cancer immunotherapy that transform cold tumors to hot tumors H Cho, K Kim Expert Opinion on Drug Delivery 21 (4), 627-638, 2024 | 5 | 2024 |
| Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy J Kim, MK Shim, Y Moon, J Kim, H Cho, WS Yun, N Shim, JK Seong, ... Journal of Nanobiotechnology 22 (1), 109, 2024 | 5 | 2024 |
| Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy J Kim, S Song, M Gwak, H Cho, WS Yun, N Hwang, J Kim, JS Lee, ... Biomaterials Research 27 (1), 102, 2023 | 5 | 2023 |
| Overcoming Cancer Drug Resistance with Nanoparticle Strategies for Key Protein Inhibition H Yoo, Y Kim, J Kim, H Cho, K Kim Molecules 29 (17), 3994, 2024 | 3 | 2024 |
| Nano-Delivery of Immunogenic Cell Death Inducers and Immune Checkpoint Blockade Agents: Single-Nanostructure Strategies for Enhancing Immunotherapy Y Moon, H Cho, K Kim Pharmaceutics 16 (6), 795, 2024 | 3 | 2024 |
| Implantable MicroLED‐Mediated Chemo‐Photodynamic Combination Therapy for Glioma Treatment J Kim, HK Lee, J Park, SI Jeon, IS Lee, WS Yun, Y Moon, J Choi, MK Shim, ... Advanced Functional Materials, 2316386, 2024 | 3 | 2024 |
